Products
Suppliers
Sourcing Requests

Post Sourcing Request Exhibition

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

You are here: Industry Insights > > TUL Degu and Liraglutide insulin compound preparation obtained clinical approval.

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Vegetable Carbon Black E153 Powder

Vegetable Carbon Black E153 Powder

Cell Wall Broken Pine Pollen

Cell Wall Broken Pine Pollen

Glutaraldehyde

Acanthopanax Bark Extract

Acanthopanax Bark Extract

Radix Pseudostellariae Extract

Radix Pseudostellariae Extract

Wrinkled Gianthyssop Extract

Wrinkled Gianthyssop Extract

TUL Degu and Liraglutide insulin compound preparation obtained clinical approval.

April 27, 2023

Tag:

Favorites

TUL Degu and Liraglutide insulin compound preparation obtained clinical approval.

Previous:350 million project construction started, and the development potential of TUL was accelerated

Next:First in China! The weight management medicine of Smeglutide Injection of TUL was approved for clini

You may like
More>>

Alizarin

J&K β-Glucosidase, from almonds, 100,000 u/g

J&K β-Glucosidase, from almonds, 100,000 u/g

2-Amino-4-methoxypyridine

2-Amino-4-methoxypyridine

5-Ethyl-2-methylpyridine

5-Ethyl-2-methylpyridine

Bis(diphenylphosphino)methane

Bis(diphenylphosphino)methane

Amoxicillin Tablet Amoxi 1G

Amoxicillin Tablet Amoxi 1G

lincomycin

5-Acetylsalicylamide

5-Acetylsalicylamide

Nw-methyl-5-hydroxytryptamine,CAS:1134-01-6

Nw-methyl-5-hydroxytryptamine,CAS:1134-01-6

TSM-1501M

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

About Us: About PharmaSources; Terms of Service; Privacy Policy; Event Data Sharing Notice; Intellectual Property; Media Partners

Buy: Search Products; Post Sourcing Requests; Search Suppliers; CAS Search

Sell: Member Application; Advertising; Post Products; EZSourcing

Events: CPHI China; PMEC China; Conferences; Search Events

Help: FAQ; Contact Us; Feedback

Copyright 2006-2025 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 滬ICP備05034851號-182 滬公網(wǎng)安備31010402010101號
Links：
CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
Follow Us：
Pharma Sources Insight July 2025

PharmaSources Customer Service

<menuitem id="ovnsb"><b id="ovnsb"></b></menuitem>